Literature DB >> 12052918

Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.

Lawrence Steinman1, Roland Martin, Claude Bernard, Paul Conlon, Jorge R Oksenberg.   

Abstract

Recent technological breakthroughs allowing for large-scale analysis of gene transcripts and large-scale monitoring of the immune response with protein chips are revealing new participants in the pathogenesis of multiple sclerosis. Some of these participants may be useful targets for therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052918     DOI: 10.1146/annurev.neuro.25.112701.142913

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  75 in total

1.  Protective effect of recombinant human IL-1Ra on CCl4-induced acute liver injury in mice.

Authors:  Run-Zhi Zhu; Di Xiang; Chao Xie; Jing-Jing Li; Jian-Jun Hu; Hong-Lin He; Yun-Sheng Yuan; Jin Gao; Wei Han; Yan Yu
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

2.  The intricate interplay among body weight, stress, and the immune response to friend or foe.

Authors:  Lawrence Steinman; Paul Conlon; Rich Maki; Alan Foster
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

3.  Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination.

Authors:  Rosetta Pedotti; Jason J DeVoss; Sawsan Youssef; Dennis Mitchell; Jochen Wedemeyer; Rami Madanat; Hideki Garren; Paulo Fontoura; Mindy Tsai; Stephen J Galli; Raymond A Sobel; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

4.  Virus persistence in an animal model of multiple sclerosis requires virion attachment to sialic acid coreceptors.

Authors:  A S Manoj Kumar; Honey V Reddi; Aisha Y Kung; Mauro Dal Canto; Howard L Lipton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 5.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

6.  IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.

Authors:  C C Walline; S Kanakasabai; J J Bright
Journal:  Genes Immun       Date:  2010-09-23       Impact factor: 2.676

7.  Peroxisome proliferator activated receptor-γ and traumatic brain injury.

Authors:  Lei Qi; Asha Jacob; Ping Wang; Rongqian Wu
Journal:  Int J Clin Exp Med       Date:  2010-09-23

Review 8.  Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  BioDrugs       Date:  2013-02       Impact factor: 5.807

9.  Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders.

Authors:  Thomas Stahnke; Christine Stadelmann; Anne Netzler; Wolfgang Brück; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

Review 10.  Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.

Authors:  Ramya Kapadia; Jae-Hyuk Yi; Raghu Vemuganti
Journal:  Front Biosci       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.